Page last updated: 2024-11-07
methyl beta-cellobioside
Description
Methyl beta-cellobioside is a cellobiose derivative that has been studied for its potential applications in various fields, including pharmaceuticals, food science, and biomaterials. It is a disaccharide composed of two glucose units linked by a beta-1,4-glycosidic bond. The methyl group is attached to the anomeric carbon of the reducing end glucose unit. Methyl beta-cellobioside can be synthesized by various methods, including enzymatic transglycosylation, chemical synthesis, and microbial fermentation. It has been shown to possess various biological activities, such as antioxidant, anti-inflammatory, and anti-diabetic properties. Moreover, it has been investigated as a potential building block for the synthesis of biodegradable polymers and other functional materials. The study of methyl beta-cellobioside is driven by its unique structural features, its potential applications in various fields, and its potential for developing novel and sustainable technologies.'
methyl beta-cellobioside: molecular model given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 111276 |
MeSH ID | M0220564 |
Synonyms (9)
Synonym |
7216-73-1 |
(2s,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxy-oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
methyl 4-o-beta-d-glucopyranosyl-beta-d-glucopyranoside |
einecs 230-604-1 |
methyl beta-cellobioside |
methyl-beta-d-cellobioside |
DTXSID101315510 |
methyl cellobioside |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.87 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.66 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |